Pestronk Lab

Alan Pestronk, MD

Research interests: Neuromuscular disorders

Clinical interests: Clinical neurology, neuromuscular disease, neuroimmunology, glycolipids, proteoglycans, aging and the nervous system, history of neurology, myopathy, neuropathy, weakness, myasthenia, muscle, nerve, numbness, sensory loss, pain, fatigue, muscular dystrophy, neuro muscular.

Learn more on the Neuromuscular Disease Center website »

Principal investigator

Alan Pestronk, MD

Alan Pestronk, MD

Professor of Neurology
Adult, Neuromuscular Medicine
Director, Neuromuscular Clinical Laboratory


  Pestronk lab

 
Top areas of adult care: myopathy, neuropathy, myasthenia gravis

Research profile
Clinical profile

Recent publications

  • Seeding-competent TDP-43 persists in human patient and mouse muscle
    Seeding-competent TDP-43 persists in human patient and mouse muscleLynch, E. M., Pittman, S., Daw, J., Ikenaga, C., Chen, S., Dhavale, D. D., Jackrel, M. E., Ayala, Y. M., Kotzbauer, P., Ly, C. V., Pestronk, A., Lloyd, T. E. & Weihl, C. C., Nov 27 2024, In: Science translational medicine. 16, 775, eadp5730.Research output: Contribution to journal › Article › peer-review
  • Ophthalmoparesis as an unusual manifestation of anti-3‑hydroxy-3-methyl-glutaryl-coenzyme A reductase antibody-associated myopathies
    Ophthalmoparesis as an unusual manifestation of anti-3‑hydroxy-3-methyl-glutaryl-coenzyme A reductase antibody-associated myopathiesPutko, B., Pestronk, A., Van Stavern, G. P., Phan, C. L., Beecher, G. & Liewluck, T., Sep 2024, In: Neuromuscular Disorders. 42, p. 1-4 4 p.Research output: Contribution to journal › Article › peer-review
  • Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial
    Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trialTawil, R., Wagner, K. R., Hamel, J. I., Leung, D. G., Statland, J. M., Wang, L. H., Genge, A., Sacconi, S., Lochmüller, H., Reyes-Leiva, D., Diaz-Manera, J., Alonso-Perez, J., Muelas, N., Vilchez, J. J., Pestronk, A., Gibson, S., Goyal, N. A., Hayward, L. J., Johnson, N. & LoRusso, S. & 19 others, Freimer, M., Shieh, P. B., Subramony, S. H., van Engelen, B., Kools, J., Leinhard, O. D., Widholm, P., Morabito, C., Moxham, C. M., Cadavid, D., Mellion, M. L., Odueyungbo, A., Tracewell, W. […]
  • Biallelic variants in COQ7 cause distal hereditary motor neuropathy with upper motor neuron signs
    Biallelic variants in COQ7 cause distal hereditary motor neuropathy with upper motor neuron signsRebelo, A. P., Tomaselli, P. J., Medina, J., Wang, Y., Dohrn, M. F., Nyvltova, E., Danzi, M. C., Garrett, M., Smith, S. E., Pestronk, A., Li, C., Ruiz, A., Jacobs, E., Feely, S. M. E., França, M. C., Gomes, M. V., Santos, D. F., Kumar, S., Lombard, D. B. & Saporta, M. & 6 others, Hekimi, S., Barrientos, A., Weihl, C., Shy, M. E., Marques, W. & Zuchner, S., Oct 1 2023, In: Brain. 146, 10, p. 4191-4199 9 p.Research output: Contribution to journal › Article › […]
  • Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI pattern
    Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI patternLlansó, L., Moore, U., Bolano-Diaz, C., James, M., Blamire, A. M., Carlier, P. G., Rufibach, L., Gordish-Dressman, H., Boyle, G., Hilsden, H., Day, J. W., Jones, K. J., Bharucha-Goebel, D. X., Salort-Campana, E., Pestronk, A., Walter, M. C., Paradas, C., Stojkovic, T., Mori-Yoshimura, M. & Bravver, E. & 4 others, Pegoraro, E., Mendell, J. R., Straub, V. & Díaz-Manera, J., Apr 2023, In: Neuromuscular Disorders. 33, 4, p. 349-357 9 p.Research output: Contribution to journal › Article › peer-review
Complete bibliography